Total Liabilities Summary of Johnson & Johnson

Johnson & Johnson's latest annual total liabilities in 2023 was 98.78 Billion USD , down -10.66% from previous year.
Johnson & Johnson's latest quarterly total liabilities in 2024 Q3 was 108.12 Billion USD , down -1.3% from previous quarter.
Johnson & Johnson reported annual total liabilities of 110.57 Billion USD in 2022, up 2.39% from previous year.
Johnson & Johnson reported annual total liabilities of 107.99 Billion USD in 2021, down -3.24% from previous year.
Johnson & Johnson reported quarterly total liabilities of 101.94 Billion USD for 2024 Q1, up 3.2% from previous quarter.
Johnson & Johnson reported quarterly total liabilities of 109.55 Billion USD for 2024 Q2, up 7.46% from previous quarter.

Annual Total Liabilities Chart of Johnson & Johnson (2023 - 1989)

Historical Annual Total Liabilities of Johnson & Johnson (2023 - 1989)

Year	Total Liabilities	Total Liabilities Growth
2023	98.78 Billion USD	-10.66%
2022	110.57 Billion USD	2.39%
2021	107.99 Billion USD	-3.24%
2020	111.61 Billion USD	13.6%
2019	98.25 Billion USD	5.42%
2018	93.2 Billion USD	-4.06%
2017	97.14 Billion USD	37.23%
2016	70.79 Billion USD	13.7%
2015	62.26 Billion USD	1.46%
2014	61.36 Billion USD	4.67%
2013	58.63 Billion USD	3.73%
2012	56.52 Billion USD	-0.08%
2011	56.56 Billion USD	22.09%
2010	46.32 Billion USD	5.07%
2009	44.09 Billion USD	3.99%
2008	42.4 Billion USD	12.66%
2007	37.63 Billion USD	20.48%
2006	31.23 Billion USD	55.0%
2005	20.15 Billion USD	-6.28%
2004	21.5 Billion USD	0.51%
2003	21.39 Billion USD	19.79%
2002	17.85 Billion USD	25.28%
2001	14.25 Billion USD	13.92%
2000	12.51 Billion USD	-3.37%
1999	12.95 Billion USD	2.61%
1998	12.62 Billion USD	38.78%
1997	9.09 Billion USD	-0.87%
1996	9.17 Billion USD	3.92%
1995	8.82 Billion USD	3.3%
1994	8.54 Billion USD	28.05%
1993	6.67 Billion USD	-0.58%
1992	6.71 Billion USD	37.36%
1991	4.88 Billion USD	6.1%
1990	4.6 Billion USD	22.14%
1989	3.77 Billion USD	4.29%

Year	Total Liabilities	Total Liabilities Growth
2024 Q3	108.12 Billion USD	-1.3%
2024 Q1	101.94 Billion USD	3.2%
2024 Q2	109.55 Billion USD	7.46%
2023 FY	98.78 Billion USD	-10.66%
2023 Q4	98.78 Billion USD	4.17%
2023 Q3	94.83 Billion USD	-17.73%
2023 Q1	125.1 Billion USD	13.14%
2023 Q2	115.27 Billion USD	-7.85%
2022 Q2	101.36 Billion USD	-2.2%
2022 Q3	100.52 Billion USD	-0.83%
2022 FY	110.57 Billion USD	2.39%
2022 Q4	110.57 Billion USD	10.0%
2022 Q1	103.64 Billion USD	-4.03%
2021 Q2	106.86 Billion USD	0.13%
2021 Q1	106.72 Billion USD	-4.38%
2021 FY	107.99 Billion USD	-3.24%
2021 Q3	108.95 Billion USD	1.96%
2021 Q4	107.99 Billion USD	-0.88%
2020 Q1	93.72 Billion USD	-4.61%
2020 Q3	106.22 Billion USD	11.34%
2020 Q2	95.4 Billion USD	1.79%
2020 Q4	111.61 Billion USD	5.08%
2020 FY	111.61 Billion USD	13.6%
2019 Q1	91.07 Billion USD	-2.29%
2019 Q3	97.31 Billion USD	3.16%
2019 Q4	98.25 Billion USD	0.97%
2019 Q2	94.33 Billion USD	3.58%
2019 FY	98.25 Billion USD	5.42%
2018 Q1	93.37 Billion USD	-3.88%
2018 Q4	93.2 Billion USD	2.33%
2018 FY	93.2 Billion USD	-4.06%
2018 Q3	91.07 Billion USD	-1.51%
2018 Q2	92.47 Billion USD	-0.96%
2017 Q4	97.14 Billion USD	18.93%
2017 Q2	80.88 Billion USD	8.46%
2017 Q1	74.57 Billion USD	5.35%
2017 FY	97.14 Billion USD	37.23%
2017 Q3	81.67 Billion USD	0.98%
2016 Q3	67.6 Billion USD	0.38%
2016 Q2	67.34 Billion USD	5.91%
2016 Q4	70.79 Billion USD	4.72%
2016 Q1	63.58 Billion USD	2.12%
2016 FY	70.79 Billion USD	13.7%
2015 FY	62.26 Billion USD	1.46%
2015 Q3	61.71 Billion USD	1.33%
2015 Q2	60.9 Billion USD	0.32%
2015 Q4	62.26 Billion USD	0.89%
2015 Q1	60.71 Billion USD	0.17%
2014 Q4	60.6 Billion USD	9.19%
2014 FY	61.36 Billion USD	4.67%
2014 Q1	56.74 Billion USD	-3.21%
2014 Q2	57.15 Billion USD	0.71%
2014 Q3	55.5 Billion USD	-2.88%
2013 Q2	54.66 Billion USD	-0.04%
2013 Q3	57.12 Billion USD	4.52%
2013 FY	58.63 Billion USD	3.73%
2013 Q4	58.63 Billion USD	2.63%
2013 Q1	54.68 Billion USD	-3.26%
2012 FY	56.52 Billion USD	-0.08%
2012 Q4	56.52 Billion USD	2.41%
2012 Q1	54.82 Billion USD	-3.07%
2012 Q2	55.31 Billion USD	0.89%
2012 Q3	55.19 Billion USD	-0.23%
2011 FY	56.56 Billion USD	22.09%
2011 Q4	56.56 Billion USD	12.47%
2011 Q3	50.29 Billion USD	0.62%
2011 Q2	49.98 Billion USD	3.51%
2011 Q1	48.28 Billion USD	4.23%
2010 Q4	46.32 Billion USD	13.12%
2010 Q3	40.95 Billion USD	3.82%
2010 Q1	40.52 Billion USD	-8.09%
2010 FY	46.32 Billion USD	5.07%
2010 Q2	39.44 Billion USD	-2.66%
2009 Q1	42.3 Billion USD	-0.22%
2009 Q2	41.19 Billion USD	-2.64%
2009 Q3	41.17 Billion USD	-0.04%
2009 Q4	44.09 Billion USD	7.09%
2009 FY	44.09 Billion USD	3.99%
2008 Q2	41.67 Billion USD	3.24%
2008 Q3	41.99 Billion USD	0.75%
2008 Q4	42.4 Billion USD	0.98%
2008 Q1	40.37 Billion USD	7.27%
2008 FY	42.4 Billion USD	12.66%
2007 Q4	37.63 Billion USD	7.25%
2007 Q3	35.09 Billion USD	11.19%
2007 Q2	31.56 Billion USD	-1.8%
2007 Q1	32.13 Billion USD	2.88%
2007 FY	37.63 Billion USD	20.48%
2006 Q3	20.66 Billion USD	2.06%
2006 Q1	21.01 Billion USD	4.25%
2006 Q4	31.23 Billion USD	51.16%
2006 FY	31.23 Billion USD	55.0%
2006 Q2	20.24 Billion USD	-3.63%
2005 FY	20.15 Billion USD	-6.28%
2005 Q3	19.72 Billion USD	1.77%
2005 Q4	20.15 Billion USD	2.16%
2005 Q2	19.38 Billion USD	-6.77%
2005 Q1	20.79 Billion USD	-3.31%
2004 Q1	20.37 Billion USD	-4.77%
2004 FY	21.5 Billion USD	0.51%
2004 Q4	21.5 Billion USD	4.51%
2004 Q3	20.57 Billion USD	2.27%
2004 Q2	20.11 Billion USD	-1.25%
2003 Q4	21.39 Billion USD	2.26%
2003 Q1	17.95 Billion USD	0.55%
2003 Q2	21.21 Billion USD	18.14%
2003 Q3	20.92 Billion USD	-1.39%
2003 FY	21.39 Billion USD	19.79%
2002 Q1	14.57 Billion USD	2.23%
2002 Q4	17.85 Billion USD	7.73%
2002 Q3	16.57 Billion USD	0.72%
2002 Q2	16.46 Billion USD	12.95%
2002 FY	17.85 Billion USD	25.28%
2001 FY	14.25 Billion USD	13.92%
2001 Q4	14.25 Billion USD	7.03%
2001 Q3	13.31 Billion USD	-0.53%
2001 Q2	13.39 Billion USD	13.64%
2001 Q1	11.78 Billion USD	-14.92%
2000 FY	12.51 Billion USD	-3.37%
2000 Q1	12.81 Billion USD	-1.06%
2000 Q2	12.32 Billion USD	-3.8%
2000 Q4	13.85 Billion USD	12.62%
2000 Q3	12.29 Billion USD	-0.23%
1999 Q4	12.95 Billion USD	1.78%
1999 Q2	12.38 Billion USD	-1.13%
1999 Q3	12.72 Billion USD	2.76%
1999 FY	12.95 Billion USD	2.61%
1999 Q1	12.52 Billion USD	-5.23%
1998 Q3	9.39 Billion USD	4.44%
1998 Q2	8.99 Billion USD	-1.25%
1998 FY	12.62 Billion USD	38.78%
1998 Q4	13.21 Billion USD	40.66%
1998 Q1	9.11 Billion USD	0.18%
1997 Q2	9.28 Billion USD	-1.73%
1997 Q4	9.09 Billion USD	-4.22%
1997 Q3	9.49 Billion USD	2.28%
1997 Q1	9.44 Billion USD	2.96%
1997 FY	9.09 Billion USD	-0.87%
1996 Q1	9.11 Billion USD	3.22%
1996 Q4	9.17 Billion USD	-0.63%
1996 Q2	9.06 Billion USD	-0.52%
1996 Q3	9.23 Billion USD	1.84%
1996 FY	9.17 Billion USD	3.92%
1995 Q4	8.82 Billion USD	0.58%
1995 Q2	8.82 Billion USD	0.77%
1995 Q3	8.77 Billion USD	-0.54%
1995 Q1	8.75 Billion USD	2.48%
1995 FY	8.82 Billion USD	3.3%
1994 Q3	7.84 Billion USD	14.94%
1994 Q4	8.54 Billion USD	9.01%
1994 Q2	6.82 Billion USD	1.29%
1994 Q1	6.73 Billion USD	0.9%
1994 FY	8.54 Billion USD	28.05%
1993 Q4	6.67 Billion USD	-0.48%
1993 Q3	6.7 Billion USD	3.04%
1993 Q2	6.5 Billion USD	1.39%
1993 FY	6.67 Billion USD	-0.58%
1993 Q1	6.41 Billion USD	-4.38%
1992 Q4	6.71 Billion USD	14.95%
1992 Q3	5.84 Billion USD	5.7%
1992 Q1	4.72 Billion USD	-3.34%
1992 FY	6.71 Billion USD	37.36%
1992 Q2	5.52 Billion USD	16.96%
1991 Q1	4.36 Billion USD	-5.19%
1991 Q3	4.49 Billion USD	3.02%
1991 Q4	4.88 Billion USD	8.67%
1991 FY	4.88 Billion USD	6.1%
1991 Q2	4.36 Billion USD	-0.05%
1990 FY	4.6 Billion USD	22.14%
1990 Q4	4.6 Billion USD	-4.2%
1990 Q3	4.8 Billion USD	4.0%
1990 Q2	4.62 Billion USD	6.18%
1990 Q1	4.35 Billion USD	15.46%
1989 FY	3.77 Billion USD	4.29%
1989 Q1	3.74 Billion USD	3.51%
1989 Q4	3.77 Billion USD	2.53%
1989 Q3	3.67 Billion USD	0.0%

Peer Total Liabilities Comparison of Johnson & Johnson

Name	Total Liabilities	Total Liabilities Difference
AbbVie Inc.	124.31 Billion USD	20.537%
Bristol-Myers Squibb Company	65.67 Billion USD	-50.416%
Bristol-Myers Squibb Company Ce	65.67 Billion USD	-50.416%
Eli Lilly and Company	53.14 Billion USD	-85.885%
Merck & Co., Inc.	69.04 Billion USD	-43.082%
Novartis AG	53.19 Billion USD	-85.702%
Organon & Co.	12.12 Billion USD	-714.512%
Pfizer Inc.	137.21 Billion USD	28.007%

Global Stocks Search

Johnson & Johnson (JNJ)

Total Liabilities Summary of Johnson & Johnson

Annual Total Liabilities Chart of Johnson & Johnson (2023 - 1989)

Historical Annual Total Liabilities of Johnson & Johnson (2023 - 1989)

Peer Total Liabilities Comparison of Johnson & Johnson